Coherus BioSciences Inc.
Coherus Oncology, Inc. leverages its biosimilar pipeline—UDOENYCA, YUSIMRY—and next‑generation immunotherapies (LOQTORZI, toripalimab co‑development) to capture U.S. oncology and biosimilars markets.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical and Diagnostic Laboratories
- Employees: 158
- HQ: Redwood City
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.